Syapse, Roche partner to further cancer-focused precision medicine

Syapse, an oncology-focused precision medicine company, entered into a multiyear strategic collaboration with Roche.

Syapse will work with Roche, which includes both pharmaceutical and diagnostics divisions, to develop software and analytics solutions to allow oncologists to practice precision medicine. Per the agreement, Roche will fund the development of the solutions, which will be built on the Syapse platform.

Syapse and Roche will initially focus on four product programs:

• Developing a "learning health system" that enables physicians to make better care decisions
• Bringing cancer care into the value-based era
• Advancing electronic patient-reported outcomes
• Accelerating clinical trial enrollment by matching patients to precision trials at the point of care

Roche and Syapse will also explore additional collaboration arenas.

More articles on data analytics & precision medicine:
23andMe launches genomics study focused on diet, exercise
Microsoft, Google venture arms invest in genomic information startup DNAnexus
4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers